Literature DB >> 10567161

Why transition from alternation to randomisation in clinical trials was made.

I Chalmers.   

Abstract

Mesh：

Year:  1999        PMID： 10567161      PMCID： PMC1117101          DOI： 10.1136/bmj.319.7221.1372

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

Review 1.  A change in scientific approach: from alternation to randomised allocation in clinical trials in the 1940s.

Authors:  P D'Arcy Hart
Journal:  BMJ       Date:  1999-08-28

Review 2.  Statistics notes. Treatment allocation in controlled trials: why randomise?

Authors:  D G Altman; J M Bland
Journal:  BMJ       Date:  1999-05-01

3.  THE SERUM TREATMENT OF LOBAR PNEUMONIA: A REPORT OF THE THERAPEUTIC TRIALS COMMITTEE OF THE MEDICAL RESEARCH COUNCIL.

Authors: 
Journal:  Br Med J       Date:  1934-02-10
  3 in total
  6 in total

1.  UK Medical Research Council and multicentre clinical trials: from a damning report to international recognition.

Authors:  Iain Chalmers
Journal:  J R Soc Med       Date:  2013-12       Impact factor: 5.344

2.  Why the 1948 MRC trial of streptomycin used treatment allocation based on random numbers.

Authors:  Iain Chalmers
Journal:  J R Soc Med       Date:  2011-09       Impact factor: 5.344

Review 3.  WITHDRAWN: Interventions for skin changes caused by nerve damage in leprosy.

Authors:  Liv Merete Reinar; Louise Forsetlund; Arild Bjørndal; Diana Nj Lockwood
Journal:  Cochrane Database Syst Rev       Date:  2019-08-01

Review 4.  Interventions for ulceration and other skin changes caused by nerve damage in leprosy.

Authors:  Liv Merete Reinar; Louise Forsetlund; Linda Faye Lehman; Kjetil G Brurberg
Journal:  Cochrane Database Syst Rev       Date:  2019-07-31

5.  A methodological framework for drug development in rare diseases.

Authors:  Patrice Nony; Polina Kurbatova; Agathe Bajard; Salma Malik; Charlotte Castellan; Sylvie Chabaud; Vitaly Volpert; Nathalie Eymard; Behrouz Kassai; Catherine Cornu
Journal:  Orphanet J Rare Dis       Date:  2014-11-18       Impact factor: 4.123

Review 6.  Errors in the implementation, analysis, and reporting of randomization within obesity and nutrition research: a guide to their avoidance.

Authors:  Colby J Vorland; Andrew W Brown; John A Dawson; Stephanie L Dickinson; Lilian Golzarri-Arroyo; Bridget A Hannon; Moonseong Heo; Steven B Heymsfield; Wasantha P Jayawardene; Chanaka N Kahathuduwa; Scott W Keith; J Michael Oakes; Carmen D Tekwe; Lehana Thabane; David B Allison
Journal:  Int J Obes (Lond)       Date:  2021-07-29       Impact factor: 5.095
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.